
Our Mission
At SciKick.Co, our mission is to accelerate innovation in the aging and longevity ecosystem. We empower startups, investors, and institutions with the strategic insight needed to navigate this complex, high-growth space. Through scientific validation, market analysis, and commercialization support, we help turn bold ideas into impactful solutions for healthier, longer lives.

Team
Founders
​
Israeli Ran has been working in life sciences for over two decades. Presently, he works for NY state department of Health helping in policy and funding decisions for aging the health care ecosystem. He previously held an academic position at the NYU as well as in Montreal and managed several research projects related to modulation of brain circuits in the healthy and diseased brain. Israeli also supports the NYU Endless Frontiers Lab – a mentorship program for startups run by NYU Stern School of Business and consults to Oppenheimer & Co. He holds a PhD in Neuroscience from the University of British Columbia.
Marc Herson is a VC investor, leadership coach and operator. He has had roles at Sony, Softbank, Harvard Business School and Investec Bank, and leads Harvest, a venture capital fund for Endeavor South Africa. He started his career as an attorney, is a certified coach and mediator, and holds an MBA from INSEAD.
​
Advisors
Prof. Ed Ziff is an NYU biochemistry professor and a world expert in synaptic regulation. His worked help elucidate the molecular mechanisms regulating glutamate receptors. Prof. Ziff has mentored many leading scientist who hold senior academic and industry positions.
​
Erez Shor, PhD - is the CEO of Exero, a startup developing a life-saving sensor for detection and prevention of inflammation during surgical procedures. Exero’s innovation has obtained FDA breakthrough designation.
​
Ethel Rubin, PhD - brings deep expertise in medical devices, translational medicine, and corporate venture strategy. She has led clinical strategy and global investments at Medtronic, advised VCs and M&A teams through her firm, Innovative BioStrategies, and served as Chief Scientific Officer at CSA Medical and BioFortis. A PhD-trained cell and molecular biologist, Ethel has held leadership roles across biotech, academia, and entrepreneurship networks, including Women In Bio and the Emerging Technology Center.